After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a
IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO
Categories
Health Care
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing
Patterson Companies, Inc. (PDCO) Q2 2022 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q2 2022 earnings call dated Dec. 01, 2021 Corporate Participants: John M. Wright -- Vice President, Investor Relations Mark
Biofrontera Inc (BFRI) Q3 2021 Earnings Call Transcript
Biofrontera Inc (NASDAQ: BFRI) Q3 2021 earnings call dated Nov. 30, 2021 Corporate Participants: Pamela Keck -- Head of Investor Relations Hermann Luebbert
BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q3 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to Bristol Myers
Centogene N.V. (CNTG) Q3 2021 Earnings Call Transcript
Centogene N.V. (NASDAQ: CNTG) Q3 2021 earnings call dated Nov. 24, 2021 Corporate Participants: Lennart Streibel -- Investor Relations Andrin Oswald -- Chief Executive Officer Rene
Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021
Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective medical procedures
Medtronic PLC (MDT) Q2 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q2 2022 earnings call dated Nov. 23, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head - Investor Relations
Colgate-Palmolive Company (CL) earnings Q3 2021 results
Colgate-Palmolive Company (NYSE: CL) reported its third-quarter financial results for the period ended September 30, 2021. GAAP net income for the third
Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook
Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom line also
Pfizer (PFE) stock research summary | Q3 2021
Pfizer delivered a solid performance in Q3 2021 with a triple-digit increase in revenue and profits growing many-fold. The company’s COVID-19 vaccine,
AbbVie (ABBV) stock research summary | Q3 2021
The AlphaStreet research report provides actionable data and insights into AbbVie’s fundamentals, the industry, and competition. The report is meant as a
Aurora Cannabis Inc. (ACB) Q1 2022 Earnings Call Transcript
Aurora Cannabis Inc. (NYSE: ACB) Q1 2022 earnings call dated Nov. 09, 2021 Corporate Participants: Ananth Krishnan -- Vice President, Corporate Development & Investor
IPO news: A few points to keep in mind as Vaxxinity makes its market debut this week
The healthcare industry continues to thrive and many companies in this sector have lined up to go public in recent times. One
Cara Therapeutics, Inc. (CARA) Q3 2021 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig -- Senior Analyst Derek Chalmers -- Chief Executive Officer,
Cigna Corporation (CI) Q3 2021 Earnings Call Transcript
Cigna Corporation (NYSE: CI) Q3 2021 earnings call dated Nov. 04, 2021 Corporate Participants: Alexis Jones -- Lead Principal, Investor Relations David Cordani -- President and
Becton, Dickinson and Company (BDX) Q4 2021 Earnings Call Transcript
Becton, Dickinson and Company (NYSE: BDX) Q4 2021 earnings call dated Nov. 04, 2021 Corporate Participants: Nadia Goncalves -- Senior Director, Investor Relations Tom
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Humana Inc. (HUM) Q3 2021 Earnings Call Transcript
Humana Inc. (NYSE: HUM) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Lisa M. Stoner -- Vice President, Investor Relations Bruce D.
Key highlights from Humana Inc. (HUM) Q3 2021 earnings results
Humana Inc. (NYSE: HUM) reported its third quarter financial results for the period ended September 30, 2021. GAAP net income for the